Suppr超能文献

携带 rpoB Ser531Leu(临床分离株中最常见的利福平耐药突变)的菌株中代偿进化的遗传特征。

Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.

机构信息

Department of Medical Biochemistry and Microbiology, Box 582 Biomedical Center, Uppsala University, Uppsala, Sweden.

出版信息

J Antimicrob Chemother. 2013 Nov;68(11):2493-7. doi: 10.1093/jac/dkt224. Epub 2013 Jun 11.

Abstract

OBJECTIVES

The evolution of rifampicin resistance in Mycobacterium tuberculosis is a major threat to effective tuberculosis therapy. Much is known about the initial emergence of rifampicin resistance, but the further evolution of these resistant strains has only lately been subject to investigation. Although resistance can be caused by many different mutations in rpoB, among clinical M. tuberculosis isolates the mutation rpoB S531L is overwhelmingly the most frequently found. Clinical isolates with rpoB S531L frequently carry additional mutations in genes for RNA polymerase subunits, and it has been speculated that these are fitness-compensatory mutations, ameliorating the fitness cost of the primary resistance mutation. We tested this hypothesis using Salmonella as a model organism.

METHODS

We created the rpoB S531L mutation in Salmonella and then evolved independent lineages with selection for mutants with increased relative fitness. Relative fitness associated with putative compensatory mutations was measured after genetic reconstruction in isogenic strains.

RESULTS

Compensatory mutations were identified in genes coding for different subunits of RNA polymerase: rpoA, rpoB and rpoC. Genetic reconstructions demonstrated that each of these secondary mutations reduced the fitness cost of the rpoB S531L resistance mutation.

CONCLUSIONS

The compensatory mutations identified in Salmonella cluster in similar locations to the additional mutations found in M. tuberculosis isolates. These new data strongly support the idea that many of the previously identified rpoA, rpoB and rpoC mutations in rifampicin-resistant M. tuberculosis (rpoB S531L) are indeed fitness-compensatory mutations.

摘要

目的

结核分枝杆菌利福平耐药性的进化是有效治疗结核病的主要威胁。人们对利福平耐药性的最初出现有了很多了解,但这些耐药菌株的进一步进化最近才受到关注。虽然 rpoB 中的许多不同突变都可能导致耐药性,但在临床结核分枝杆菌分离株中,rpoB S531L 突变是最常见的。具有 rpoB S531L 突变的临床分离株经常携带 RNA 聚合酶亚基基因的其他突变,人们推测这些是适应性补偿突变,可以减轻主要耐药突变的适应性代价。我们使用沙门氏菌作为模型生物来验证这一假说。

方法

我们在沙门氏菌中创建了 rpoB S531L 突变,然后通过选择具有更高相对适应性的突变体来进化独立的谱系。在同基因菌株中进行遗传重建后,测量与假定补偿突变相关的相对适应性。

结果

鉴定出与 RNA 聚合酶不同亚基编码的补偿突变:rpoA、rpoB 和 rpoC。遗传重建表明,这些二次突变中的每一个都降低了 rpoB S531L 耐药突变的适应性代价。

结论

在沙门氏菌中鉴定出的补偿突变与在结核分枝杆菌分离株中发现的额外突变聚集在相似的位置。这些新数据有力地支持了这样一种观点,即以前在耐利福平的结核分枝杆菌(rpoB S531L)中鉴定出的许多 rpoA、rpoB 和 rpoC 突变确实是适应性补偿突变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验